kras mutation and glutathion glynac

kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Targeting KRAS mutations: orchestrating cancer

Name: kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Targeting KRAS mutations: orchestrating cancer
Brand: lagence-mr.com
SKU: 19980302485
Price: 26.37 USD
Availability: InStock
Rating: 4.859500000000001 (8 reviews)

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI Isoform Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D: Cell Reports Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC

SKU: 19980302485 · From lagence-mr.com

4.9

USD26.37 USD52.37

Pay in 4 interest-free payments of $6.59 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 13 - Sep 18

Description

1 Our lungs also have a high amount of glutathione

M.et al (2012)

OCA treatment ameliorated high-fat diet (HFD)-induced dysplasia, potentially by reducing deleterious secondary BAs (e.g., DCA, TDCA), decreasing microbial bile salt hydrolase (BSH) expression, and favorably reshaping the tumors immune landscape (128), thereby potentially reversing an immunosuppressive TIME